TY - JOUR
T1 - Easy and robust electrotransfection protocol for efficient ectopic gene expression and genome editing in human B cells
AU - Canoy, Reynand Jay
AU - André, Franck
AU - Shmakova, Anna
AU - Wiels, Joëlle
AU - Lipinski, Marc
AU - Vassetzky, Yegor
AU - Germini, Diego
N1 - Publisher Copyright:
© 2020, Springer Nature Limited.
PY - 2023/2/1
Y1 - 2023/2/1
N2 - B-cell lines and primary PBMCs are notoriously hard to transfect, thus making genome editing, ectopic gene expression, or gene silencing experiments particularly tedious. Here we propose a novel efficient and reproducible protocol for electrotransfection of lymphoblastoid, B-cell lymphoma, leukemia cell lines, and B cells from PBMCs. The proposed protocol requires neither costly equipment nor expensive reagents; it can be used with small or large plasmids. Transfection and viability rates of about 79% and 58%, respectively, have been routinely achieved by optimizing the salt concentration in the electrotransfection medium and the amount of plasmid used. A validation of the protocol was obtained via the generation of a TP53−/− RPMI8866 lymphoblastoid cell line which should prove useful in future hematological and blood cancer studies.
AB - B-cell lines and primary PBMCs are notoriously hard to transfect, thus making genome editing, ectopic gene expression, or gene silencing experiments particularly tedious. Here we propose a novel efficient and reproducible protocol for electrotransfection of lymphoblastoid, B-cell lymphoma, leukemia cell lines, and B cells from PBMCs. The proposed protocol requires neither costly equipment nor expensive reagents; it can be used with small or large plasmids. Transfection and viability rates of about 79% and 58%, respectively, have been routinely achieved by optimizing the salt concentration in the electrotransfection medium and the amount of plasmid used. A validation of the protocol was obtained via the generation of a TP53−/− RPMI8866 lymphoblastoid cell line which should prove useful in future hematological and blood cancer studies.
UR - http://www.scopus.com/inward/record.url?scp=85091725666&partnerID=8YFLogxK
U2 - 10.1038/s41434-020-00194-x
DO - 10.1038/s41434-020-00194-x
M3 - Article
C2 - 32999452
AN - SCOPUS:85091725666
SN - 0969-7128
VL - 30
SP - 167
EP - 171
JO - Gene Therapy
JF - Gene Therapy
IS - 1-2
ER -